BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33421118)

  • 1. PTBP1 is necessary for dendritic cells to regulate T-cell homeostasis and antitumour immunity.
    Geng G; Xu C; Peng N; Li Y; Liu J; Wu J; Liang J; Zhu Y; Shi L
    Immunology; 2021 May; 163(1):74-85. PubMed ID: 33421118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis.
    Zhang H; Wang D; Li M; Plecitá-Hlavatá L; D'Alessandro A; Tauber J; Riddle S; Kumar S; Flockton A; McKeon BA; Frid MG; Reisz JA; Caruso P; El Kasmi KC; Ježek P; Morrell NW; Hu CJ; Stenmark KR
    Circulation; 2017 Dec; 136(25):2468-2485. PubMed ID: 28972001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM.
    Xie R; Chen X; Chen Z; Huang M; Dong W; Gu P; Zhang J; Zhou Q; Dong W; Han J; Wang X; Li H; Huang J; Lin T
    Cancer Lett; 2019 May; 449():31-44. PubMed ID: 30742945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of lactate-lysosome axis in dendritic cells by clotrimazole potentiates antitumor immunity.
    Wang Z; Xu F; Hu J; Zhang H; Cui L; Lu W; He W; Wang X; Li M; Zhang H; Xiong W; Xie C; Liu Y; Zhou P; Liu J; Huang P; Qin XF; Xia X
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skipping of exon 10 in
    Shen L; Lei S; Zhang B; Li S; Huang L; Czachor A; Breitzig M; Gao Y; Huang M; Mo X; Zheng Q; Sun H; Wang F
    Theranostics; 2020; 10(13):5719-5735. PubMed ID: 32483414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial deletion of PTBP1 disrupts ventricular chamber development.
    Liu H; Duan R; He X; Qi J; Xing T; Wu Y; Zhou L; Wang L; Shao Y; Zhang F; Zhou H; Gu X; Lin B; Liu Y; Wang Y; Liu Y; Li L; Liang D; Chen YH
    Nat Commun; 2023 Mar; 14(1):1796. PubMed ID: 37002228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Characterization of a Minimal Functional Splicing Regulatory Protein, PTBP1.
    Ontiveros RJ; Hernandez L; Nguyen H; Hernandez Lopez AL; Shankar A; Kim E; Keppetipola NM
    Biochemistry; 2020 Dec; 59(50):4766-4774. PubMed ID: 33284593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of PTBP1 promote invasion of colorectal cancer by alternative splicing of cortactin.
    Wang ZN; Liu D; Yin B; Ju WY; Qiu HZ; Xiao Y; Chen YJ; Peng XZ; Lu CM
    Oncotarget; 2017 May; 8(22):36185-36202. PubMed ID: 28404950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTBP1 enhances exon11a skipping in Mena pre-mRNA to promote migration and invasion in lung carcinoma cells.
    Li S; Shen L; Huang L; Lei S; Cai X; Breitzig M; Zhang B; Yang A; Ji W; Huang M; Zheng Q; Sun H; Wang F
    Biochim Biophys Acta Gene Regul Mech; 2019 Aug; 1862(8):858-869. PubMed ID: 31075540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The RNA-Binding Protein, Polypyrimidine Tract-Binding Protein 1 (PTBP1) Is a Key Regulator of CD4 T Cell Activation.
    La Porta J; Matus-Nicodemos R; Valentín-Acevedo A; Covey LR
    PLoS One; 2016; 11(8):e0158708. PubMed ID: 27513449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells.
    Calabretta S; Bielli P; Passacantilli I; Pilozzi E; Fendrich V; Capurso G; Fave GD; Sette C
    Oncogene; 2016 Apr; 35(16):2031-9. PubMed ID: 26234680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of BCL-X splicing reveals a role for the polypyrimidine tract binding protein (PTBP1/hnRNP I) in alternative 5' splice site selection.
    Bielli P; Bordi M; Di Biasio V; Sette C
    Nucleic Acids Res; 2014 Oct; 42(19):12070-81. PubMed ID: 25294838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypyrimidine tract binding protein 1 regulates the activation of mouse CD8 T cells.
    D'Angeli V; Monzón-Casanova E; Matheson LS; Gizlenci Ö; Petkau G; Gooding C; Berrens RV; Smith CWJ; Turner M
    Eur J Immunol; 2022 Jul; 52(7):1058-1068. PubMed ID: 35460072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation and functional significance of CDC42 alternative splicing in ovarian cancer.
    He X; Yuan C; Yang J
    Oncotarget; 2015 Oct; 6(30):29651-63. PubMed ID: 26336992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant Exon 8/8a Splicing by Downregulated PTBP (Polypyrimidine Tract-Binding Protein) 1 Increases Ca
    Lei J; Liu X; Song M; Zhou Y; Fan J; Shen X; Xu X; Kapoor I; Zhu G; Wang (王觉进) J
    Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2440-2453. PubMed ID: 32787518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTBP1-dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesis.
    Izaguirre DI; Zhu W; Hai T; Cheung HC; Krahe R; Cote GJ
    Mol Carcinog; 2012 Nov; 51(11):895-906. PubMed ID: 21976412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A developmentally regulated spliced variant of PTBP1 is upregulated in type 1 diabetic hearts.
    Belanger K; Nutter CA; Li J; Yu P; Kuyumcu-Martinez MN
    Biochem Biophys Res Commun; 2019 Feb; 509(2):384-389. PubMed ID: 30594394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pan-cancer analysis of the oncogenic role of polypyrimidine tract binding protein 1 (PTBP1) in human tumors.
    Huang Q; Gu S; Fang J; Li X; Lin L
    Medicine (Baltimore); 2022 Dec; 101(52):e32428. PubMed ID: 36595978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-133b inhibits growth of human gastric cancer cells by silencing pyruvate kinase muscle-splicer polypyrimidine tract-binding protein 1.
    Sugiyama T; Taniguchi K; Matsuhashi N; Tajirika T; Futamura M; Takai T; Akao Y; Yoshida K
    Cancer Sci; 2016 Dec; 107(12):1767-1775. PubMed ID: 27696637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
    Oba T; Makino K; Kajihara R; Yokoi T; Araki R; Abe M; Minderman H; Chang AE; Odunsi K; Ito F
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.